title: [Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent Deposiston. Hormonal contraceptives and caffeine elimination].
abstract: In the course of six months, the influence of the oral depot contraceptive, Deposiston (3 mg ethinylestradiol sulphonate and 10 mg norethisterone acetate per menstrual cycle) on the pharmacokinetics of caffeine as a model substance was studied in seven women in intraindividual comparison. The first examination began prior to administration of Deposition. The women were subjected to little challenge as saliva was used as the measuring compartment. Deposiston was found markedly delay the elimination half-life life of caffeine (p less than 0.05): t1/2 prior to therapy 4.9 +/- 2.6 h and, after as little as 2 mg ethinylestradiol sulphonate 8.0 +/- 3.5 h. In contrast to the effect observed for preparations containing less estrogen, these longer half-lives persisted throughout the trial. As expected, the AUC values were slightly elevated during this period, whereas clearance values were reduced.
authors.affiliation: Institut für Klinische Pharmakologie, Medizinischen Akademie Magdeburg.
authors.forename: F P
authors.initials: FP
authors.lastname: Meyer
authors.forename: E
authors.initials: E
authors.lastname: Canzler
authors.forename: H
authors.initials: H
authors.lastname: Giers
authors.forename: H
authors.initials: H
authors.lastname: Walther
mesh_terms: D000328:Adult; D002110:Caffeine / Q000493:pharmacokinetics*; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D009640:Norethindrone / Q000494:pharmacology*; D012463:Saliva / Q000378:metabolism
chemical_list: D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D002110:Caffeine; D004997:Ethinyl Estradiol; C011436:Deposiston; D009640:Norethindrone
vernacular_title: Zeitverlauf der Hemmung der Coffeinelimination unter dem Einfluss des oralen Depotkontrazeptivum Deposiston. Hormonale Kontrazeptiva und Coffeinelimination.